Abstract
Background In general, survival outcome for head and neck cancer (HNC) patients has improved. However, mortality within six months after diagnosis with curative intent remains high. The aim of this study was to identify risk factors for early death among patients with curative treatment, and furthermore, to analyze whether the risk of early death changed over the recent years.
Material and Method This real-world, population-based, nationwide study from the Swedish Head and Neck Cancer Register (SweHNCR) included 16,786 patients with curative treatment decision at the multidisciplinary tumor board from 2008 to 2020.
Results During the study period a total of 618 (3.7%) patients with curative-intended treatment died within six months from diagnosis. Patients diagnosed between 2008–2012 had a six-month mortality rate of 4.7% compared to 2.5% for patients diagnosed 2017–2020, indicating a risk reduction of 53% (p <0.001) for death within six months. The mean time to radiation therapy in the 2008–2012 cohort was 38 days, compared to 22 days for the 2017– 2020 cohort, (p<0.001). The mean time to surgery from diagnosis was 22 days in 2008–2012, compared to 15 days for the 2017–2020 cohort, (p <0.001).
Females had a 20% lower risk of dying within six months compared to males (p =0.013). For every year older the patient was at diagnosis, a 4.8% (p <0.001) higher risk of dying within six months was observed. Patients with a WHO score of 1 had approximately 2.4-times greater risk of early death compared to WHO 0 patients (p <0.001). The risk of early death among WHO 4 patients was almost 28 times higher than for WHO 0 patients (p <0.001)
Conclusions We found that the risk of early death decreased significantly from 2008 to 2020. During this period the mean time to the start of treatment, was significantly reduced both for surgery and oncological treatment regimes. Among patients with a curative treatment intention, increased risk of early death was associated with male sex, older age, advanced disease, increased WHO score, and a hypopharyngeal tumor site.
Brief description *The risk of early death decreased significantly from 2008 to 2020.
*Time from diagnosis to treatment decreased between 2008 to 2020.
*Among patients with a curative treatment intention, increased risk of early death was associated with male sex, older age, advanced disease, increased WHO score, and a hypopharyngeal tumor site.
Ethical Considerations The Regional Ethical Review Board in Gothenburg and Lund reviewed and approved the study, (Gothenburg, number 299–14, T230-17 and Lund 2020-01972). This study was carried out in accordance with the current Helsinki Declaration of the World Medical Association from 2013. Data are available upon request.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee approval Gothenburg, number 299–14, T230-17 and Lund 2020-01972
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
